NCT06132191 2025-11-20
Expanded Access Use of Cemiplimab in Patients With Solid Tumors
Regeneron Pharmaceuticals
Approved for marketing
Clinical Trials
3 trialsNCT03089658 2019-10-09
Expanded Access to Avelumab for Treatment of Metastatic Merkel Cell Carcinoma (mMCC)
Merck KGaA, Darmstadt, Germany
Approved for marketing
NCT01160250 2015-08-06
A Study of Vismodegib (GDC-0449) in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
Genentech, Inc.
Approved for marketing